Wordt geladen...
Early versus delayed autologous stem cell transplantation in patients receiving novel therapies for Multiple Myeloma
Autologous stem cell transplant (ASCT) is an effective treatment for multiple myeloma (MM). However the timing of ASCT in the era of novel agents (lenalidomide, thalidomide, bortezomib) is unknown. We retrospectively reviewed the outcome of MM patients who received novel agent based induction treatm...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3769940/ https://ncbi.nlm.nih.gov/pubmed/23194056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.751528 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|